Phosphoric Acid — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRB1 ADRB2 ADRB3 CYP11B1 DPP4 FGFR1 FGFR2 FGFR3 FGFR4 HRH1 JAK1 JAK2 JAK3 KCNA1 KCNA10 KCNA2 KCNA3 KCNA4 KCNA5 KCNA6 KCNA7 KCNB1 KCNB2 KCNC1 KCNC2 KCNC3 KCNC4 KCND1 KCND2 KCND3 KCNF1 KCNG1 KCNG2 KCNG3 KCNG4 KCNH1 KCNH2 KCNH3 KCNH4 KCNH5 KCNH6 KCNH7 KCNH8 KCNQ1 KCNQ2 KCNQ3 KCNQ4 KCNQ5 KCNS1 KCNS2 KCNS3 KCNV1 KCNV2 KDR KIT NA OPRD1 OPRK1 OPRM1 P PDGFRB PIK3CD SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SMO TYK2 pol rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	CYP1A2	P05177	1/20	0.44

▸	TSHR	P16473	3/20	0.42

▸	MEN1	O00255	1/20	0.42

▸	LMNA	P02545	1/20	0.42

▸	CYP2D6	P10635	1/20	0.42

▸	KMT2A	Q03164	1/20	0.42

▸	TAS2R10	Q9NYW0	1/20	0.42

▸	KDM4E	B2RXH2	1/20	0.41

▸	ALDH1A1	P00352	1/20	0.41

▸	TDP1	Q9NUW8	1/20	0.41

▸	CHRNA7	P36544	2/20	0.40

▸	CHRNB4	P30926	1/20	0.40

▸	CHRNA3	P32297	1/20	0.40

▸	CETP	P11597	4/20	0.39

▸	FDPS	P14324	1/20	0.39

▸	BCHE	P06276	1/20	0.38

▸	ACHE	P22303	1/20	0.38

▸	LAP3	P28838	3/20	0.38

▸	ANPEP	P15144	1/20	0.38

▸	CES2	O00748	1/20	0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Phosphoric Acid SCHEMBL8506894	0.96	CYP1A2 (0.44)	CYP1A2TSHRMEN1LMNACYP2D6
Phosphoric Acid SCHEMBL28146726	0.95	CYP1A2 (0.43)	CYP1A2TSHRMEN1LMNACYP2D6
Phosphoric Acid SCHEMBL8506893	0.92	CYP1A2 (0.46)	CYP1A2TSHRMEN1LMNACYP2D6
Phosphoric Acid SCHEMBL8506891	0.92	CYP1A2 (0.50)	CYP1A2TSHRMEN1LMNACYP2D6
Phosphoric Acid SCHEMBL7637618	0.91	CYP1A2 (0.49)	CYP1A2TSHRMEN1LMNACYP2D6
Bicarbonate SCHEMBL315104	0.85	LMNA (0.50)	CYP1A2TSHRMEN1LMNACYP2D6
Bicarbonate SCHEMBL315102	0.85	LMNA (0.50)	CYP1A2TSHRMEN1LMNACYP2D6
Phosphoric Acid SCHEMBL7635575	0.84	TSHR (0.45)	TSHRKDM4EALDH1A1TDP1FDPS
Bicarbonate SCHEMBL315103	0.84	CYP1A2 (0.49)	CYP1A2TSHRMEN1LMNACYP2D6
Methyl Alcohol SCHEMBL27837342	0.84	KDM4E (0.50)	CYP1A2TSHRMEN1LMNACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3219708-B1	PROCESS FOR PRODUCING POLYVALENT GLYCIDYL COMPOUND	SHOWA DENKO KK (JP)	2019-10-23	—	—	EP	disclosed
US-10160737-B2	Process for producing polyvalent glycidyl compound	SHOWA DENKO K.K. (JP)	2018-12-25	—	—	US	disclosed
EP-3135677-B1	ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME	JX NIPPON OIL & ENERGY CORP (JP)	2018-10-10	—	—	EP	disclosed
US-20170342042-A1	PROCESS FOR PRODUCING POLYVALENT GLYCIDYL COMPOUND	SHOWA DENKO K.K. (JP)	2017-11-30	—	—	US	disclosed
EP-3219708-A1	PROCESS FOR PRODUCING POLYVALENT GLYCIDYL COMPOUND	Showa Denko K.K. (JP)	2017-09-20	—	—	EP	disclosed
US-9695186-B2	Alicyclic diepoxy compound having bis-spironorbornane structure, method for producing the same, and use thereof	JX NIPPON OIL & ENERGY CORPORATION (JP)	2017-07-04	—	—	US	disclosed
EP-3135677-A1	ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME	JX Nippon Oil & Energy Corporation (JP)	2017-03-01	—	—	EP	disclosed
US-20170044179-A1	ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF	JX NIPPON OIL & ENERGY CORPORATION (JP)	2017-02-16	—	—	US	disclosed
US-20160074856-A1	RECOVERY METHOD AND REUSE METHOD OF OXO ACID CATALYST	DAICEL CORPORATION (JP)	2016-03-17	—	—	US	disclosed
EP-2990110-A1	RECOVERY METHOD AND REUSE METHOD OF OXO ACID CATALYST	Daicel Corporation (JP)	2016-03-02	—	—	EP	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-10160737-B2	Process for producing polyvalent glycidyl compound	HAO2, NOX4, PPOX	CYP1A2 3160/4885TSHR 3109/4885MEN1 3882/4885
US-20160074856-A1	RECOVERY METHOD AND REUSE METHOD OF OXO ACID CATALYST	HAO2, HAO1, AOX1	CYP1A2 142/4885TSHR 1773/4885MEN1 4522/4885
US-20170342042-A1	PROCESS FOR PRODUCING POLYVALENT GLYCIDYL COMPOUND	HAO2, NOX4, PPOX	CYP1A2 3160/4885TSHR 3109/4885MEN1 3882/4885
US-20170044179-A1	ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF	DHCR7, HSD17B7, CYP17A1	CYP1A2 552/4885TSHR 1775/4885MEN1 407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.